Building a $100B AI Engine Ft. Matt Domo
*please note limited seating for the private dinner, starting at 7:30pm
Building a $100B AI Engine | Ft. Matt Domo
The existential threat to your company isn't that AI won't work; it's that your leadership team will "schedule another meeting" while the market moves without you.
While the world debated whether the cloud was a fad, Matt Domo was in the room with Jeff Bezos and Bill Gates, architecting the database infrastructure that now powers one-third of the internet. As a co-founder of Amazon Web Services (AWS), Matt didn’t just witness a $100B revolution; he helped engineer it. Now, he’s joining Silicon Zombies to dismantle the noise, and show us how to build a proprietary ecosystem that actually thrives.
The Engineering Diagnosis: Why 80% of AI Fails
Matt’s thesis is sharp: Technology is easy; trust is hard. Most AI projects die in the boardroom because they are "people problems wearing a tech costume." We’re diving into his #1 bestseller, Everybody Wins, to move AI from theory to production by solving the "Commoditization Trap."
We’re breaking down the "Mission Possible" playbook:
The "Age of ME": Shifting from rigid systems that force human conformity to AI that adaptively learns the individual.
The 20% Rule: Why the only AI projects that scale are the ones born from a decision, not a committee.
True Defensibility: Why models are commoditizing at light speed, and why your only real moat is the architecture you build around the model.
The Architect of the Frontier
Matt Domo is an AWS Co-Founder, Chairman of the Space Force Association, and has been named the "Top AI Leader to Follow" by MSN. He is a protector by nature and an architect by trade, dedicated to ensuring that as AI scales at a planetary level, it reorients humanity toward more meaningful work.
Huge thanks to our sponsors:
The Park James Hotel - Menlo Parks #1 Luxury Hotel
TUOM - Natural formulas to balance your mood and sharpen your focus
UpMarket - Pre-IPO access. SpaceX, Anthropic, and beyond
Necodex - Nearshore Teams: Scale Fast with Trusted Talent
TrueBinding - Blocking Galectin-3 to stop age-related inflammation. We’re scaling for the future while treating patients today through Expanded Access.